Cornerstone Research assisted counsel during the Glaxo and Burroughs Wellcome merger, which created the largest pharmaceutical firm in the world.
Retained by Simpson Thacher & Bartlett
Cornerstone Research assisted counsel during the Glaxo and Burroughs Wellcome merger, which created the largest pharmaceutical firm in the world. As part of the merger agreement, Glaxo agreed to divest a substantial research project. Working with Professors Michael Gibbons of the Wharton School and Professor Henry Grabowski of Duke University, we analyzed the procompetitive effect of the research project’s divestiture.